Related Experiment Video

Updated: Jul 3, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Unbiased estimation of selected treatment means in two-stage trials

Jack Bowden1, Ekkehard Glimm

  • 1MRC Biostatistics Unit, Cambridge, CB2 0SR, UK. jack.bowden@mrc-bsu.cam.ac.uk

Biometrical Journal. Biometrische Zeitschrift
|July 30, 2008
PubMed

Insights

This study introduces an improved unbiased estimation method for adaptive clinical trials, enabling accurate selection of top-performing treatments even with unequal sample sizes and for various ranks (j-th best). Simulations explore the benefits of this flexible approach.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmaceutical Development

Background:

  • Adaptive clinical trials accelerate drug development by selecting promising treatments early.
  • Treatment selection based on rank order can introduce bias in effect estimation.
  • Existing unbiased estimation methods have limitations regarding sample sizes and rank flexibility.

Purpose of the Study:

  • To extend existing unbiased estimation methods for adaptive clinical trials.
  • To address bias introduced by treatment selection mechanisms.
  • To provide a flexible estimation framework for identifying top-ranked treatments.

Main Methods:

  • Extension of the Cohen and Sackrowitz (1989) two-stage unbiased estimation method.
  • Adaptation for unequal sample sizes across trial stages.
  • Application to estimate the best, second best, or j-th best treatment effect.

Main Results:

  • The extended method provides unbiased estimates for various treatment ranks.
  • The approach accommodates unequal sample sizes in stage one and stage two.
  • Simulations demonstrate the practical implications of this enhanced flexibility.

Conclusions:

  • The developed method offers a more flexible and unbiased approach to treatment effect estimation in adaptive trials.
  • This enhances the ability to accurately identify and fast-track promising drug candidates.
  • The findings have significant implications for optimizing clinical trial efficiency and drug discovery.

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...